Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 May;84(9):2610–2614. doi: 10.1073/pnas.84.9.2610

24- and 26-homo-1,25-dihydroxyvitamin D3: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro.

V K Ostrem, Y Tanaka, J Prahl, H F DeLuca, N Ikekawa
PMCID: PMC304707  PMID: 3033654

Abstract

1,25-Dihydroxyvitamin D3, the hormonal form of vitamin D3, promotes the differentiation of HL-60 human promyelocytic leukemia cells into monocytes. Differentiation changes include the induction of phagocytosis, the initiation of nitroblue tetrazolium-reducing activity, and the appearance of nonspecific acid esterase. We have found that the 24-homo- and 26-homo-1,25-dihydroxyvitamin D3 and their delta 22 analogues are 10-fold more potent than 1,25-dihydroxyvitamin D3 in inducing differentiation of HL-60 cells in vitro. In vivo, these analogues show activity similar to 1,25-dihydroxyvitamin D3 in stimulating intestinal calcium transport in vitamin D-deficient rats. The 24-homoanalogues are significantly less active, whereas the 26-homo derivatives are more active than the natural hormone in mobilizing calcium from bone. This unusual activity pattern cannot be explained on the basis of the affinity of these analogues for the 1,25-dihydroxyvitamin D3 intracellular receptor: both 24-homo- and 26-homo-1,25-dihydroxyvitamin D3 have the same effectiveness as 1,25-dihydroxyvitamin D3 in displacing the tritiated hormone from its receptor in rat intestine or HL-60 cells. These analogues of 1,25-dihydroxyvitamin D3 may be of some interest as possible therapeutic substances, or as tools in understanding the action of 1,25-dihydroxyvitamin D3 in inducing differentiation.

Full text

PDF
2610

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe E., Miyaura C., Sakagami H., Takeda M., Konno K., Yamazaki T., Yoshiki S., Suda T. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4990–4994. doi: 10.1073/pnas.78.8.4990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bar-Shavit Z., Teitelbaum S. L., Reitsma P., Hall A., Pegg L. E., Trial J., Kahn A. J. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1983 Oct;80(19):5907–5911. doi: 10.1073/pnas.80.19.5907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blunt J. W., Tanaka Y., DeLuca H. F. Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. Proc Natl Acad Sci U S A. 1968 Dec;61(4):1503–1506. doi: 10.1073/pnas.61.4.1503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brumbaugh P. F., Haussler M. R. Nuclear and cytoplasmic receptors for 1,25-dihydroxycholecalciferol in intestinal mucosa. Biochem Biophys Res Commun. 1973 Mar 5;51(1):74–80. doi: 10.1016/0006-291x(73)90509-3. [DOI] [PubMed] [Google Scholar]
  5. Dame M. C., Pierce E. A., DeLuca H. F. Identification of the porcine intestinal 1,25-dihydroxyvitamin D3 receptor on sodium dodecyl sulfate/polyacrylamide gels by renaturation and immunoblotting. Proc Natl Acad Sci U S A. 1985 Dec;82(23):7825–7829. doi: 10.1073/pnas.82.23.7825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DeLuca H. F., Schnoes H. K. Vitamin D: recent advances. Annu Rev Biochem. 1983;52:411–439. doi: 10.1146/annurev.bi.52.070183.002211. [DOI] [PubMed] [Google Scholar]
  7. Honma Y., Hozumi M., Abe E., Konno K., Fukushima M., Hata S., Nishii Y., DeLuca H. F., Suda T. 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci U S A. 1983 Jan;80(1):201–204. doi: 10.1073/pnas.80.1.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jarnagin K., Brommage R., DeLuca H. F., Yamada S., Takayama H. 1- but not 24-hydroxylation of vitamin D is required for growth and reproduction in rats. Am J Physiol. 1983 Mar;244(3):E290–E297. doi: 10.1152/ajpendo.1983.244.3.E290. [DOI] [PubMed] [Google Scholar]
  9. Koeffler H. P., Amatruda T., Ikekawa N., Kobayashi Y., DeLuca H. F. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. Cancer Res. 1984 Dec;44(12 Pt 1):5624–5628. [PubMed] [Google Scholar]
  10. Kream B. E., Reynolds R. D., Knutson J. C., Eisman J. A., DeLuca H. F. Intestinal cytosol binders of 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D. Arch Biochem Biophys. 1976 Oct;176(2):779–787. doi: 10.1016/0003-9861(76)90222-8. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Mangelsdorf D. J., Koeffler H. P., Donaldson C. A., Pike J. W., Haussler M. R. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol. 1984 Feb;98(2):391–398. doi: 10.1083/jcb.98.2.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Martin D. L., DeLuca H. F. Influence of sodium on calcium transport by the rat small intestine. Am J Physiol. 1969 Jun;216(6):1351–1359. doi: 10.1152/ajplegacy.1969.216.6.1351. [DOI] [PubMed] [Google Scholar]
  14. McCarthy D. M., San Miguel J. F., Freake H. C., Green P. M., Zola H., Catovsky D., Goldman J. M. 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res. 1983;7(1):51–55. doi: 10.1016/0145-2126(83)90057-7. [DOI] [PubMed] [Google Scholar]
  15. Merke J., Klaus G., Hügel U., Waldherr R., Ritz E. No 1,25-dihydroxyvitamin D3 receptors on osteoclasts of calcium-deficient chicken despite demonstrable receptors on circulating monocytes. J Clin Invest. 1986 Jan;77(1):312–314. doi: 10.1172/JCI112292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Napoli J. L., Mellon W. S., Fivizzani M. A., Schnoes H. K., DeLuca H. F. Direct chemical synthesis of 1 alpha,25-dihydroxy[26,27-3H]vitamin D3 with high specific activity: its use in receptor studies. Biochemistry. 1980 May 27;19(11):2515–2521. doi: 10.1021/bi00552a033. [DOI] [PubMed] [Google Scholar]
  17. Norman A. W., Roth J., Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev. 1982 Fall;3(4):331–366. doi: 10.1210/edrv-3-4-331. [DOI] [PubMed] [Google Scholar]
  18. Raisz L. G., Trummel C. L., Holick M. F., DeLuca H. F. 1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science. 1972 Feb 18;175(4023):768–769. doi: 10.1126/science.175.4023.768. [DOI] [PubMed] [Google Scholar]
  19. Shepard R. M., Horst R. L., Hamstra A. J., DeLuca H. F. Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J. 1979 Jul 15;182(1):55–69. doi: 10.1042/bj1820055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shiina Y., Abe E., Miyaura C., Tanaka H., Yamada S., Ohmori M., Nakayama K., Takayama H., Matsunaga I., Nishii Y. Biological activity of 24,24-difluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone in inducing differentiation of human myeloid leukemia cells. Arch Biochem Biophys. 1983 Jan;220(1):90–94. doi: 10.1016/0003-9861(83)90390-9. [DOI] [PubMed] [Google Scholar]
  21. Stumpf W. E., Sar M., Reid F. A., Tanaka Y., DeLuca H. F. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science. 1979 Dec 7;206(4423):1188–1190. doi: 10.1126/science.505004. [DOI] [PubMed] [Google Scholar]
  22. Suda T., DeLuca H. F., Tanaka Y. Biological activity of 25-hydroxyergocalciferol in rats. J Nutr. 1970 Sep;100(9):1049–1052. doi: 10.1093/jn/100.9.1049. [DOI] [PubMed] [Google Scholar]
  23. Tanaka H., Abe E., Miyaura C., Kuribayashi T., Konno K., Nishii Y., Suda T. 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J. 1982 Jun 15;204(3):713–719. doi: 10.1042/bj2040713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tanaka Y., Deluca H. F., Schnoes H. K., Ikekawa N., Kobayashi Y. 24,24-difluoro-1,25-dihydroxyvitamin D3: in vitro production, isolation, and biological activity. Arch Biochem Biophys. 1980 Feb;199(2):473–478. doi: 10.1016/0003-9861(80)90304-5. [DOI] [PubMed] [Google Scholar]
  25. Tanaka Y., Sicinski R. R., DeLuca H. F., Sai H., Ikekawa N. Unique rearrangement of ergocalciferol side chain in vitro: production of a biologically highly active homologue of 1,25-dihydroxyvitamin D3. Biochemistry. 1986 Sep 23;25(19):5512–5518. doi: 10.1021/bi00367a025. [DOI] [PubMed] [Google Scholar]
  26. Williams D., Gorski J. Equilibrium binding of estradiol by uterine cell suspensions and whole uteri in vitro. Biochemistry. 1974 Dec 31;13(27):5537–5542. doi: 10.1021/bi00724a013. [DOI] [PubMed] [Google Scholar]
  27. Yen A., Reece S. L., Albright K. L. Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: precommitment memory associated with altered nuclear structure. J Cell Physiol. 1984 Mar;118(3):277–286. doi: 10.1002/jcp.1041180310. [DOI] [PubMed] [Google Scholar]
  28. Zull J. E., Repke D. W. The tissue localization of tritiated parathyroid hormone in thyroparathyroidectomized rats. J Biol Chem. 1972 Apr 10;247(7):2195–2199. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES